10.1002/jps.2600700608.abs Four series of p‐(3,5‐diphenylpyrazole‐1)‐, p‐(5‐(p‐chlorophenyl)‐3‐phenylpyrazole‐1)‐, p‐(5‐(p‐chlorophenyl)‐4‐hydroxy‐3‐phenyl‐2‐pyrazolin‐1‐yl)‐, and p‐(5‐(p‐chlorophenyl)‐4‐hydroxy‐3‐phenylpyrazole‐1)benzenesulfonylurea derivatives were prepared for evaluation as hypoglycemic agents. Preliminary biological testing revealed that the new compounds possess potent hypoglycemic activity.
End of preview. The entire article is 5 pages. Rent for Free